Lynx1 Capital Management LP 13D and 13G filings for Passage Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 09:01 am Purchase |
2024-12-31 | 13G | Passage Bio, Inc. PASG |
Lynx1 Capital Management LP | 9,256,953 15.000% |
829,998 (+9.85%) |
Filing |
| 2024-08-09 5:15 pm Purchase |
2024-08-07 | 13G | Passage Bio, Inc. PASG |
Lynx1 Capital Management LP | 8,426,955 13.600% |
3,581,084 (+73.90%) |
Filing |
| 2024-03-29 4:15 pm Purchase |
2024-03-19 | 13G | Passage Bio, Inc. PASG |
Lynx1 Capital Management LP | 4,845,871 8.700% |
4,466,712 (+1178.06%) |
Filing |
| 2024-02-14 09:21 am Sale |
2023-12-31 | 13G | Passage Bio, Inc. PASG |
Lynx1 Capital Management LP | 379,159 0.700% |
-2,976,758 (-88.70%) |
Filing |
| 2023-02-14 4:06 pm Purchase |
2022-12-31 | 13G | Passage Bio, Inc. PASG |
Lynx1 Capital Management LP | 3,355,917 6.200% |
603,495 (+21.93%) |
Filing |
| 2022-09-29 4:30 pm Purchase |
2022-09-19 | 13G | Passage Bio, Inc. PASG |
Lynx1 Capital Management LP | 2,752,422 5.100% |
2,752,422 (New Position) |
Filing |